| Views | |
|---|---|
| Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials | 122 |
| November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials | 4 | 7 | 13 | 9 | 10 | 6 | 7 |
| Views | |
|---|---|
| Pokrovskiy_Safety_21.pdf | 45 |
| Views | |
|---|---|
| United States | 37 |
| Canada | 19 |
| Brazil | 4 |
| Germany | 4 |
| United Kingdom | 4 |
| Mongolia | 3 |
| Russia | 3 |
| Australia | 2 |
| Colombia | 2 |
| EU | 2 |
| Views | |
|---|---|
| Ottawa | 17 |
| Mountain View | 8 |
| Englewood | 5 |
| San Francisco | 4 |
| Ulaanbaatar | 3 |
| Houston | 2 |
| Nanterre | 2 |
| Seattle | 2 |
| Voronezh | 2 |
| Warrington | 2 |